Columbia University Vagelos College of Physicians and Surgeons (VP&S) today announced the launch of its new Center for Pediatric Cardiovascular Innovation, made possible by a gift from Lawrence Neubauer. The new center’s mission is to improve patient outcomes through breakthrough research and treatments, and to define the next treatments and future practices for congenital heart disease (CHD), here and around the world.

The center will be named the Garrett Isaac Neubauer Center for Cardiovascular Innovation in memory of Lawrence Neubauer’s son, Garrett, who died of CHD in 2001. The $50 million center was established with a $15 million gift from Lawrence Neubauer and additional support from Columbia. Irving University Medical Center and NewYork-Presbyterian Church.

A new center in Columbia aims to help more children born with heart disease not only survive to adulthood, but thrive.

“I know I speak for my colleagues, Dr. Christopher Petit, Dr. Emile Bacha, and everyone at Columbia University and NewYork-Presbyterian, we are extremely grateful to Larry for this gift. ,” said Jordan S. Orange, M.D., Jordan S. Orange, M.D., and Ruben S. Carpentier, professor of pediatrics and director of the center’s division of pediatrics. Vice President and Chief Physician of NewYork-Presbyterian Morgan Stanley Children’s Hospital. “Thanks to Larry’s generosity, we will be able to make even greater and more rapid progress in transforming the care of children born with heart disease.”

“The Garrett Isaac Neubauer Center for Cardiovascular Innovation will allow Columbia University to expand and improve pediatric care for children with heart disease and continue its long history of finding answers to the most complex scientific questions in pediatric cardiology. We can,” said Dr. Katrina Armstrong.Dean of the Faculty of Health Sciences and Vagelos College of Physicians and Surgeons and,Vice President for Health and Biomedical Sciences at Columbia University. “Larry’s gift will serve as the perfect catalyst to leverage current efforts in basic and translational research at Columbia University and accelerate progress in CHD treatment. ”

“The Garrett Isaac Neubauer Center for Cardiovascular Innovation will build on our long tradition of providing the highest quality and most compassionate care to children with heart disease and their families,” said New York President and Chief Executive Officer. said director Stephen J. Corwin, MD. Presbyterian. “With Larry’s visionary support, we will continue to advance the treatment of congenital heart disease so that young patients can thrive.”

CHD is present at birth and can affect the structure of your baby’s heart and how it works. Congenital heart defects can range from mild (such as a small hole in the heart) to severe (such as a missing or hypoplastic part of the heart). Approximately 40,000 babies are born with congenital heart defects in the United States each year.

Columbia University has cutting-edge faculty expertise in areas related to congenital heart disease, with world-renowned leaders across pediatric cardiology, pediatric cardiac surgery, and all pediatric subspecialties. Masu. The Garrett Isaac Neubauer Cardiovascular Innovation Center is headed by Orange, Christopher Petit, M.D., chief of pediatric cardiology, and Emil Basha, MD, chief of cardiac, thoracic and vascular surgery.

In addition to accelerating research to better understand CHD and the care of patients and their families, the new center will leverage the existing resources and strengths of Columbia and NewYork-Presbyterian’s pediatric cardiology and cardiac surgery programs. To do. Specifically, the Center will:

• Measure outcomes after CHD surgery/interventions to identify the most appropriate treatment for a specific condition and establish evidence-based benchmarks for performance.
• We will conduct research to understand why some infants develop CHD and how to treat it. The Neubauer Center will leverage Columbia’s existing resources, including major programs in genetics and functional genomics, to define the mechanisms underlying CHD. Cardiac xenotransplantation to expand the pool of available donor organs. Developing valves to improve the treatment of pediatric heart valve disease. 3D printing guides complex pediatric heart surgery while improving today’s outcomes.
• Recruit and train the next generation of experts in CHD and pediatric cardiology.

Lawrence Neubauer shared news of his gift with attendees at Columbia University’s annual Baby Heart Foundation Gala, where he was recognized for his support of pediatric cardiology.

“After losing Garrett, we wanted to help other families avoid a situation like ours,” Neubauer said. “We know that by collaborating with Columbia, we can support new research and care that will help many other families and patients facing congenital heart disease. His memory is our inspiration. Garrett would have turned 22 in 2023.